medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2018, Number 2

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2018; 16 (2)

Actinomycetomas in Chiapas. A Report of 15 Cases at Centro Dermatológico del Sureste Dr. Fernando Latapí

López VF, Aquino FC, Aquino JMÁ, Palafox VG, Farrera EF, Arenas GR

Language: Spanish
References: 23
Page: 116-122
PDF size: 210.30 Kb.


ABSTRACT

Background: mycetoma is a chronic granulomatous infection due to actynomicetes and fungi. Nocardia brasiliensis is the most common isolated causal agent in México. Treatment is based on dapsone and trimethoprim sulfametoxazol.
Objective: to report sociodemographic situation, clinical features and microbiological aspects of patients affected by mycetoma in the state of Chiapas.
Methodology: a retrospective and observational study was performed at Centro Dermatológico del Sureste Dr. Fernando Latapí, in the city of Tuxtla Gutiérrez, Chiapas, from 1997 to 2017.
Results: in 20 years we found 15 cases of mycetoma. Nocardia spp. was identified in 86% and Actinomadura madurae in 14%. Male and female ratio was 4:1, age ranged from 15 to 70 years with a average age of 27.5 years. Trunk and legs where equally affected in 46% of the cases. Evolution ranged from five months to 15 years.
Discussion: in Chiapas, mycetoma is caused mainly by Nocardia spp. (86%) and Actinomadura (14%) and usually affects trunk and lower limbs. Treatment of choice is dapsone plus trimetroprim sulfametoxasol, and in five cases norfloxacin was added with good results.


REFERENCES

  1. Padilla M, Caballero A y Martínez E, Micetoma por Nocardia brasiliensis en región abdominal, Rev Cent Dermatol Pascua 2014; 23(1):17-21.

  2. Torres E, Vásquez E y Moreno G, Micetomas actinomicéticos. Resultados terapéuticos en 15 casos, Dermatología Rev Mex 2008; 52(2):65-9.

  3. Welsh O, Al Abdely H, Salinas-Carmona M et al., Mycetoma medical therapy, plos Negl Trop Dis 2014; 8(10):e3218.

  4. Arenas R. Micología médica ilustrada, México, McGraw-Hill Interamericana, 2016.

  5. Mohamed HT, Fahal A y Van de Sade, Mycetoma: epidemiology, treatment challengues, and progress, Res and Rep in Tro Med 2015; 6:31-6.

  6. Hernández-Bel P, Mayorga J y Pérez M E, Actinomicetoma por Nocardia brasiliensis, An Pediatr 2010; 73(4):213-4.

  7. López R, Méndez L y Bonifaz A, Actualización de la epidemiología del micetoma en México. Revisión de 3 933 casos, Gaceta Médica de México 2013; 149:586-92.

  8. Bonifaz A, Tirado-Sánchez A, Calderón L, Saúl A et al., Mycetoma: experience of 482 cases in a single center in Mexico, plos Negl Trop Dis 2014; 8(8):e3102.

  9. Sánchez-Cárdenas C, García-Abundis M, Ruiz J et al., Actinomicetomas por Nocardia spp. Informe de 8 casos en Izúcar de Matamoros, Puebla, Dermatología cmq 2017; 15(3):162-7.

  10. Jérez R y Schafer F, Micetoma actinomicético por Actinomadura madurae, Rev Chil Infectol 2012; 29(4):459-63.

  11. inegi. Clima. Chiapas 2018.

  12. López-Zaldo JB, Hernandez-Ortega AP, Arias-Amaral J et al., Micetoma abdominal, manifestación inusual tratada con imipenem y amikacina, Med Int Mex 2013; 29:436-41.

  13. Machado A, Una década de micología en el Centro Dermatológico de Yucatán, Dermatología cmq 2012; 10(1):6-7.

  14. Sánchez C, García MI, Ruiz J et al., Actinomicetomas por Nocardia spp. Informe de ocho casos en Izúcar de Matamoros, Puebla, Dermatología cmq 2017; 15(3):162-7.

  15. Welsh O, Mycetoma, Clinics in Dermatology 2007; 25:195-202.

  16. Kumar J, Kumar A, Sethy P et al., A dot-in-circle sign of mycetoma in mri, Diagn Interv Radiol 2007; 3:193-5.

  17. Palit A, Ragunatha S e Inamadar A, Actinomycetoma: dramatic response to modified two-step regimen, Int J Dermatol 2011; 50:446-9.

  18. Bonifaz A, Vázquez-González D y Perusquía-Ortiz A, Subcutaneous mycoses: chromoblastomycosis, sporotrichosis and mycetoma, J Dtsch Dermatol Ges 2010; 8(8):619-27.

  19. Hassan A, Management of mycetoma, Expert Rev Dematol 2010; 5(1):1-7.

  20. Gómez A, Welsh O y Said S, In vitro and in vivo activities of antimicrobials against Nocardia brasiliensis, Antimicrob Agents Chemother 2004; 48(3):832-7.

  21. Schalberg R, Fisher M, Hanson K et al., Suceptibility profiles of Nocardia isolates based on current taxonomy, Antimicrob Agents Chemother 2014; 58:795-800.

  22. Welsh O, Vera-Cabrera L, Welsh E et al., Actinomycetoma and advances in its treatment, Clin Dermatol 2012; 30(4):372-81.

  23. Chacón-Moreno BE, Welsh O, Cavazos-Rocha N et al., Efficacy of ciprofloxacin and moxifloxacin against Nocardia brasiliensis in vitro and in an experimental model of actinomycetoma in balb/c mice, Antimicrob Agents Chemother 2009; 53(1):295-7.




2020     |     www.medigraphic.com